|
| |
medigene l1 Pages on BioPortfolio:
BioPortfolio - MediGene AG - Profile
View the current MediGene AG Page on BioPortfolio.com .... 6352696- Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/26247-MediGene%2525...
|
BioPortfolio - MediGene Germany
BioPortfolio - medigene l1 as an L1 fusion protein has been conducted at MediGene AG (Germany), NCI, and. the University of Queensland (Australia). ...
http://www.bioportfolio.com/search/MediGene_Germany.html...
|
BioPortfolio - MediGene AG - Profile
Medigene AG (NMarkt: MDG) is a publicly quoted German biopharmaceutical .... 6352696- Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/6855-MediGene+AG.pd...
|
BioPortfolio - medigene cvlp
Recent Search Terms used to find this page MediGene aav | medigene psoriasis | medigene ag etomoxir | medigene cvlp patent | medigene l1 | medigene | . ...
http://www.bioportfolio.com/search/medigene_cvlp.html...
|
BioPortfolio - MediGene AG
MediGene AG - Entry on Bioportfolio's Biocorporate Database. ... 6352696, Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/6855-MediGene_AG.ht...
|
BioPortfolio - MediGene AG
MediGene AG (Frankfurt, Prime Standard: MDG) announces that the European Patent Office has granted a patent on the application of anti-L1 antibodies in . ...
http://www.bioportfolio.com/search/MediGene_AG.html...
|
BioPortfolio - MediGene AG - Profile
Pharma Live: Sep 10 2008 10:26AM Matching: medigene ag. • MediGene wins European patent for anti-L1 antibody against ovarian cancer ...
http://www.bioportfolio.com/biocorporate/6855-MediGene%2BAG....
|
BioPortfolio - Celltrion - Profile
MediGene wins European patent for anti-L1 antibody against ovarian cancer. Sharewatch: Aug 19 2008 6:58AM Matching: celltrion ...
http://www.bioportfolio.com/biocorporate/20632-Celltrion.pdf...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - MediGene AG - Profile
Medigene AG (NMarkt: MDG) is a publicly quoted German biopharmaceutical .... 6352696- Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/6855-MediGene+AG.pd...
|
MediGene AG Publishes 9-Months-Report 2008 - Sales and EBITDA ...
MediGene exercised option on anti-L1 antibody for cancer therapy, and continues collaboration with the DKFZ (German Cancer Research Center) ...
http://www.biospace.com/news_story.aspx?NewsEntityId=116530...
|
BioPortfolio - MediGene AG - Profile
View the current MediGene AG Page on BioPortfolio.com .... 6352696- Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/26247-MediGene%2525...
|
BioSpace - MediGene, Inc. News, Search Jobs, Events
MediGene, Inc. Release: European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy 8/20/2008 8:17:39 AM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=4242...
|
BioPortfolio - MediGene AG
MediGene AG - Entry on Bioportfolio's Biocorporate Database. ... 6352696, Papillomavirus truncated L1 protein and fusion protein constructs ...
http://www.bioportfolio.com/biocorporate/6855-MediGene_AG.ht...
|
Deal Highlights
Celltrion and MediGene agree to codevelop. mAbs against L1. MediGene AG and Celltrion Inc have signed a memorandum. of understanding under which the ...
http://www.biomedcentral.com/content/pdf/cd-862945.pdf...
|
Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific ...
Immunization with papillomavirus L1 capsomeres triggers neutralizing .... from pCEP4HPV16L1ΔC (kindly provided by A. Burger, MediGene AG, Martinsried, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15...
|
Understanding racial-ethnic and societal differentials in STI
group) and HPV16 L1–E7 CVLP (by. Medigene)—have passed or are passing. safety and immunogenicity tests. In. addition to the induction of high titres of ...
http://www.cdc.gov/std/research/2002/aral-sti-2002-78-1.pdf...
|
HPV Vaccines:
as an L1 fusion protein has been conducted at MediGene AG (Germany), NCI, and. the University of Queensland (Australia). 40,50,52. These vaccines include L1 ...
http://www.path.org/files/jsrp13710.pdf...
|
BioSpace - German Cancer Research Center (DKFZ) News, Search Jobs ...
MediGene AG (DX:MDG) Exercises Option for Anti-L1 Monoclonal Antibody and Continues Collaboration With German Cancer Research Center (DKFZ) 7/17/2008 ...
http://www.biospace.com/company_profile.aspx?CompanyId=96602...
|
|